327 related articles for article (PubMed ID: 27470453)
21. CHA
Xing Y; Sun Y; Li H; Tang M; Huang W; Zhang K; Zhang D; Zhang D; Ma Q
Clin Interv Aging; 2018; 13():497-504. PubMed ID: 29636604
[TBL] [Abstract][Full Text] [Related]
22. Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation. An analysis of 425,600 Chinese individuals without prior stroke.
Guo Y; Wang H; Tian Y; Wang Y; Lip GY
Thromb Haemost; 2016 Jan; 115(1):184-92. PubMed ID: 26322338
[TBL] [Abstract][Full Text] [Related]
23. Discriminative Ability of CHA
Schwartz SM; Tedla YG; Greenland P; Yadlapati A; Passman RS
Am J Cardiol; 2019 Jun; 123(12):1949-1954. PubMed ID: 30979410
[TBL] [Abstract][Full Text] [Related]
24. The value of the European society of cardiology guidelines for refining stroke risk stratification in patients with atrial fibrillation categorized as low risk using the anticoagulation and risk factors in atrial fibrillation stroke score: a nationwide cohort study.
Lip GYH; Nielsen PB; Skjøth F; Lane DA; Rasmussen LH; Larsen TB
Chest; 2014 Nov; 146(5):1337-1346. PubMed ID: 25086251
[TBL] [Abstract][Full Text] [Related]
25. The Value of the CHADS
Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449
[TBL] [Abstract][Full Text] [Related]
26. A comparison of the CHARGE-AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study.
Christophersen IE; Yin X; Larson MG; Lubitz SA; Magnani JW; McManus DD; Ellinor PT; Benjamin EJ
Am Heart J; 2016 Aug; 178():45-54. PubMed ID: 27502851
[TBL] [Abstract][Full Text] [Related]
27. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF
Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082
[TBL] [Abstract][Full Text] [Related]
28. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
[TBL] [Abstract][Full Text] [Related]
29. Stroke Risk as a Function of Atrial Fibrillation Duration and CHA
Kaplan RM; Koehler J; Ziegler PD; Sarkar S; Zweibel S; Passman RS
Circulation; 2019 Nov; 140(20):1639-1646. PubMed ID: 31564126
[TBL] [Abstract][Full Text] [Related]
30. Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Lip GY; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
Stroke; 2016 Oct; 47(10):2462-9. PubMed ID: 27625386
[TBL] [Abstract][Full Text] [Related]
31. CHA
Chen LY; Norby FL; Chamberlain AM; MacLehose RF; Bengtson LGS; Lutsey PL; Alonso A
Stroke; 2019 Jan; 50(1):28-33. PubMed ID: 30580712
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation.
Akboğa MK; Yılmaz S; Yalçın R
Anatol J Cardiol; 2021 Nov; 25(11):789-795. PubMed ID: 34734812
[TBL] [Abstract][Full Text] [Related]
33. Echocardiographic parameters versus CHA2DS2-VASc score in prediction of overall cardiac events, heart failure, and stroke in non-valvular atrial fibrillation.
Yang LT; Tsai WC; Su HM
Cardiol J; 2018; 25(1):60-71. PubMed ID: 28714523
[TBL] [Abstract][Full Text] [Related]
34. Anticoagulation for atrial fibrillation patients with the CHA2DS2-VASc score =1 (beyond sex).
Xie X; Li T
Acta Cardiol; 2021 May; 76(3):258-264. PubMed ID: 32056508
[TBL] [Abstract][Full Text] [Related]
35. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
[TBL] [Abstract][Full Text] [Related]
36. [The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics].
Liu XB; Jia ZX; Xia SJ; He L; Lu SX; Guo XY; Li SN; Liu N; Jiang CX; Sang CH; Tang RB; Long DY; Yu RH; Bai R; Wu JH; Du X; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):735-739. PubMed ID: 32957755
[No Abstract] [Full Text] [Related]
37. CHA
Rapacciuolo A; Mancusi C; Canciello G; Izzo R; Strisciuglio T; de Luca N; Ammirati G; de Simone G; Trimarco B; Losi MA
Sci Rep; 2019 May; 9(1):7888. PubMed ID: 31133712
[TBL] [Abstract][Full Text] [Related]
38. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of the CHA
Kuo L; Chao TF; Liu CJ; Chen SJ; Tuan TC; Lin YJ; Chang SL; Lo LW; Hu YF; Chung FP; Liao JN; Chen TJ; Lip GYH; Chen SA
Am J Cardiol; 2018 Dec; 122(12):2049-2054. PubMed ID: 30342698
[TBL] [Abstract][Full Text] [Related]
40. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS
Chapman SA; St Hill CA; Little MM; Swanoski MT; Scheiner SR; Ware KB; Lutfiyya MN
BMC Health Serv Res; 2017 Feb; 17(1):127. PubMed ID: 28187730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
